Occupational exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and risk of infection among healthcare personnel

被引:11
|
作者
Shah, Vishal P. [1 ,2 ]
Breeher, Laura E. [1 ,3 ]
Alleckson, Julie M. [3 ]
Rivers, David G. [3 ]
Wang, Zhen [2 ]
Stratton, Emily R. [1 ]
Farah, Wigdan [1 ]
Hainy, Caitlin M. [3 ]
Swift, Melanie D. [1 ,3 ]
机构
[1] Mayo Clin, Div Prevent Occupat & Aerosp Med, Rochester, MN 55905 USA
[2] Mayo Clin, Evidence Based Practice Res Program, Rochester, MN 55905 USA
[3] Mayo Clin, Occupat Hlth Serv, Rochester, MN USA
关键词
COVID-19; WORKERS;
D O I
10.1017/ice.2021.533
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To assess the rate and factors associated with healthcare personnel (HCP) testing positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) after an occupational exposure. Design: Retrospective cohort study. Setting: Academic medical center with sites in Minnesota, Wisconsin, Arizona, and Florida. Participants: HCP with a high or medium risk occupational exposure to a patient or other HCP with SARS-CoV-2. Methods: We reviewed the records of HCP with significant occupational exposures from March 20, 2020, through December 31, 2020. We then performed regression analysis to assess the impact of demographic and occupational variables to assess their impact on the likelihood of testing positive for SARS-CoV-2. Results: In total, 2,253 confirmed occupational exposures occurred during the study period. Employees were the source for 57.1% of exposures. Overall, 101 HCP (4.5%) tested positive in the postexposure period. Of these, 80 had employee sources of exposure and 21 had patient sources of exposure. The postexposure infection rate was 6.2% when employees were the source, compared to 2.2% with patient sources. In a multivariate analysis, occupational exposure from an employee source had a higher risk of testing positive compared to a patient source (odds ratio [OR], 3.22; 95% confidence interval [CI], 1.72-6.04). Sex, age, high-risk exposure, and HCP role were not associated with an increased risk of testing positive. Conclusions: The risk of acquiring coronavirus disease 2019 (COVID-19) following a significant occupational exposure has remained relatively low, even in the prevaccination era. Exposure to an infectious coworker carries a higher risk than exposure to a patient. Continued vigilance and precautions remain necessary in healthcare settings.
引用
收藏
页码:1785 / 1789
页数:5
相关论文
共 50 条
  • [31] Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020-April 2021
    Bosserman, Rachel E.
    Farnsworth, Christopher W.
    O'Neil, Caroline A.
    Cass, Candice
    Park, Daniel
    Ballman, Claire
    Wallace, Meghan A.
    Struttmann, Emily
    Stewart, Henry
    Arter, Olivia
    Peacock, Kate
    Fraser, Victoria J.
    Budge, Philip J.
    Olsen, Margaret A.
    Burnham, Carey-Ann D.
    Babcock, Hilary M.
    Kwon, Jennie H.
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2023, 3 (01):
  • [32] Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) exposure investigations using genomic sequencing among healthcare workers and patients in a large academic center
    Smith, Leigh
    Morris, C. Paul
    Jibowu, Morgan H.
    Fallon, Susan
    Ray, Stuart C.
    Cosgrove, Sara E.
    Curless, Melanie S.
    Fabre, Valeria
    Karaba, Sara M.
    Maragakis, Lisa L.
    Milstone, Aaron M.
    Sick-Samuels, Anna C.
    Trexler, Polly
    Mostafa, Heba H.
    Rock, Clare
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2023, 44 (05): : 798 - 801
  • [33] Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients
    Duffy, Cassandra R.
    Hart, Jessica M.
    Modest, Anna M.
    Hacker, Michele R.
    Golen, Toni
    Li, Yunping
    Zera, Chloe
    Shainker, Scott A.
    Mehrotra, Preeti
    Zash, Rebecca
    Wylie, Blair J.
    OBSTETRICS AND GYNECOLOGY, 2020, 136 (02): : 229 - 231
  • [34] Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic
    Rosser, Joelle, I
    Roltgen, Katharina
    Dymock, Melissa
    Shepard, John
    Martin, Andrew
    Hogan, Catherine A.
    Blomkalns, Andra
    Mathew, Roshni
    Parsonnet, Julie
    Pinsky, Benjamin A.
    Maldonado, Yvonne A.
    Boyd, Scott D.
    Chang, Sang-ick
    Holubar, Marisa
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (09): : 1053 - 1059
  • [35] Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Among Healthcare Workers Dining in Hospital Staff Cafeterias
    Jung, Jiwon
    Lim, Young-Ju
    Kim, Eun Ok
    Kim, Sung-Han
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (02)
  • [36] An overview of research on air and environmental contamination with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in healthcare settings
    Kanamori, Hajime
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (01): : 130 - 133
  • [37] Universal masking to control healthcare-associated transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2)
    Thompson, Eliza R.
    Williams, Faith S.
    Giacin, Pat A.
    Drummond, Shay
    Brown, Eric
    Nalick, Meredith
    Wang, Qian
    McDonald, Jay R.
    Carlson, Abigail L.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (03): : 344 - 350
  • [38] Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection
    Odumade, Oludare A.
    van Haren, Simon D.
    Angelidou, Asimenia
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (SUPPL 1) : S130 - S135
  • [39] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review
    Wei Feng
    Wei Zong
    Feng Wang
    Shaoqing Ju
    Molecular Cancer, 19
  • [40] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review
    Feng, Wei
    Zong, Wei
    Wang, Feng
    Ju, Shaoqing
    MOLECULAR CANCER, 2020, 19 (01)